Aspira Women's Health Announces Appointment of Dr. Sandra Milligan as Interim CEO

Stock Information for null

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About null

Aspira Women's Health Inc. to Begin Trading April 17th On OTC Under the Symbol "AWHL"
Aspira Women's Health Inc. Announces Receipt of Delisting Notification from Nasdaq
Aspira Appoints Three New Directors, Executes $2.0 Million Equity Purchase Agreement
Aspira Receives $1.5 million Milestone Payment from the ARPA-H Sprint for Women's Health Award
Aspira Women's Health Reports Fourth Quarter and Full Year 2024 Financial Results
Aspira Women's Health Announces Closing of $1.37 Million Private Placement of Convertible Notes
Aspira Women's Health Submits Request for Withdrawal of Form S-1 Registration Statement
Aspira Women's Health Announces Appointment of Ellen Beausang to the Board of Directors

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.